• Acquisition reflects steady Internationalisation gains for Diagnostics Group
    Christian Dreher (left) and Scott Gilroy
  • Scott Gilroy (left) and Christian Dreher

News & Views

Acquisition reflects steady Internationalisation gains for Diagnostics Group

Jun 08 2022

German biotech R-Biopharm AG has progressed its internationalisation strategy by entering new clinical diagnostics market sectors through the acquisition of AusDiagnostics, a specialist and manufacturer of molecular biology multiplex diagnostics, extraction reagents and laboratory automation equipment.

"The existing and future molecular biology multiplex analysis platforms for syndrome testing from system supplier AusDiagnostics broadens our molecular biology expertise and perfectly complements our present clinical diagnostics portfolio," said Christian Dreher, CEO of Darmstadt located R-Biopharm. "The acquisition strengthens our position as a reliable partner for system solutions and offers our customers additional options for diagnostics."

Established in 2006, the Australian company brought its patented Multiplex Tandem PCR (MT-PCR) to market with current technology enabling simultaneous detection of up to 24 pathogens or resistance genes from a single sample.

AusDiagnostics CEO Scott Gilroy commented on the transaction as marking an exciting new chapter for the company: "Both AusDiagnostics and R-Biopharm AG share the same commitment to innovation in the biotechnology space. This acquisition strengthens AusDiagnostics and will accelerate our global presence. We've experienced tremendous, industry-leading growth over the past two years, which has been underpinned by our broad suite of innovative products, talented team and incredible, loyal customers. Joining the R-Biopharm group will allow us to further build on this and continue to deliver exceptional products and service for our Australian and international customers."

Currently employing 92 people and with offices in New Zealand, the USA and Great Britain, AusDiagnostics’ production facilities in Australia and Great Britain supply a steadily growing network of more than 25 distributors and partners around the world - from which R-Biopharm expects further synergy effects for production as well as international service and support in its clinical diagnostics line.

More information online

Digital Edition

Lab Asia 31.3 June 2024

June 2024

Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - UV-Vis and fluorescence spectroscopy illumina...

View all digital editions



Jun 26 2024 Tokyo, Japan

Asia Labex

Jul 03 2024 Gandhinagar, India

EuCheMS Chemistry Congress

Jul 07 2024 Dublin, Ireland

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

View all events